Selumetinib

Results: 18



#Item
1Award ID: DP150074 Project Title: Inhibitors of Hydrogen Sulfide Biosynthesis: Preclinical Development of Novel Colorectal Cancer Therapies Award Mechanism:

Award ID: DP150074 Project Title: Inhibitors of Hydrogen Sulfide Biosynthesis: Preclinical Development of Novel Colorectal Cancer Therapies Award Mechanism:

Add to Reading List

Source URL: www.cprit.state.tx.us

Language: English - Date: 2014-11-20 01:49:47
2Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas

Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas

Add to Reading List

Source URL: www.translational-medicine.com

Language: English
3BRAF V600E Mutation Detection Howard Robin, M.D. Revised[removed]HIGHLIGHTS

BRAF V600E Mutation Detection Howard Robin, M.D. Revised[removed]HIGHLIGHTS

Add to Reading List

Source URL: molecularresponse.com

Language: English - Date: 2014-11-19 02:15:21
4Clinical Thyroidology Volume 25 Issue 5 May 2013

Clinical Thyroidology Volume 25 Issue 5 May 2013

Add to Reading List

Source URL: www.thyroid.org

Language: English - Date: 2013-11-08 16:38:07
5New biomarker may help guide treatment of melanoma patients

New biomarker may help guide treatment of melanoma patients

Add to Reading List

Source URL: medicalxpress.com

Language: English - Date: 2015-02-25 23:08:29
6Targeted agent selumetinib shows promise in biliary cancer

Targeted agent selumetinib shows promise in biliary cancer

Add to Reading List

Source URL: phys.org

Language: English - Date: 2015-02-08 12:40:06
7How Can We Implement Strategies For A Breast Cancer Genomically-Driven Trial?

How Can We Implement Strategies For A Breast Cancer Genomically-Driven Trial?

Add to Reading List

Source URL: www.fda.gov

Language: English
8Clinical THYROIDOLOGY VOLUME 25 • ISSUE 4 Editor-in Chief

Clinical THYROIDOLOGY VOLUME 25 • ISSUE 4 Editor-in Chief

Add to Reading List

Source URL: www.thyroid.org

Language: English - Date: 2013-11-08 16:38:04
9Development of Trametinib in Pediatric Tumor Indications    GSK Oncology

Development of Trametinib in Pediatric Tumor Indications GSK Oncology

Add to Reading List

Source URL: www.fda.gov

Language: English
10OVERVIEW Trovagene is currently partnering with Memorial Sloan Kettering Cancer Center and MD Anderson on two clinical studies enrolling ECD patients to evaluate urine-based cellfree tumor DNA testing to diagnose BRAF mu

OVERVIEW Trovagene is currently partnering with Memorial Sloan Kettering Cancer Center and MD Anderson on two clinical studies enrolling ECD patients to evaluate urine-based cellfree tumor DNA testing to diagnose BRAF mu

Add to Reading List

Source URL: www.erdheim-chester.org

Language: English - Date: 2014-06-13 09:52:00